These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11815719)

  • 21. Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response.
    Ojeda-Fernández L; Recio-Poveda L; Aristorena M; Lastres P; Blanco FJ; Sanz-Rodríguez F; Gallardo-Vara E; de las Casas-Engel M; Corbí Á; Arthur HM; Bernabeu C; Botella LM
    PLoS Genet; 2016 Mar; 12(3):e1005935. PubMed ID: 27010826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β Signaling in Control of Cardiovascular Function.
    Goumans MJ; Ten Dijke P
    Cold Spring Harb Perspect Biol; 2018 Feb; 10(2):. PubMed ID: 28348036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.
    Lesca G; Plauchu H; Coulet F; Lefebvre S; Plessis G; Odent S; Rivière S; Leheup B; Goizet C; Carette MF; Cordier JF; Pinson S; Soubrier F; Calender A; Giraud S;
    Hum Mutat; 2004 Apr; 23(4):289-99. PubMed ID: 15024723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality.
    Torsney E; Charlton R; Diamond AG; Burn J; Soames JV; Arthur HM
    Circulation; 2003 Apr; 107(12):1653-7. PubMed ID: 12668501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex.
    Blanco FJ; Santibanez JF; Guerrero-Esteo M; Langa C; Vary CP; Bernabeu C
    J Cell Physiol; 2005 Aug; 204(2):574-84. PubMed ID: 15702480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.
    Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM
    Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) and malignant melanoma in two patients.
    Kluger N; Riviére S; Coupier I; Bessis D; Guillot B
    Melanoma Res; 2007 Jun; 17(3):201-3. PubMed ID: 17505266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
    Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
    Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
    Lebrin F; Mummery CL
    Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling by the transforming growth factor-beta receptors.
    Yingling JM; Wang XF; Bassing CH
    Biochim Biophys Acta; 1995 Dec; 1242(2):115-36. PubMed ID: 7492567
    [No Abstract]   [Full Text] [Related]  

  • 32. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
    Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
    Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor.
    Sorensen LK; Brooke BS; Li DY; Urness LD
    Dev Biol; 2003 Sep; 261(1):235-50. PubMed ID: 12941632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.
    Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of hereditary hemorrhagic telangiectasia and hereditary nonpolyposis colorectal cancer in the same kindred.
    Goldschmidt N; Metzger S; Wexler ID; Goldshmidt O; Hershcovici T; Chajek-Shaul T
    Int J Cancer; 2005 Sep; 116(5):808-12. PubMed ID: 15849752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular morphogenesis: tales of two syndromes.
    Marchuk DA; Srinivasan S; Squire TL; Zawistowski JS
    Hum Mol Genet; 2003 Apr; 12 Spec No 1():R97-112. PubMed ID: 12668602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia.
    Argyriou L; Pfitzmann R; Wehner LE; Twelkemeyer S; Neuhaus P; Nayernia K; Engel W
    Liver Transpl; 2005 Sep; 11(9):1132-5. PubMed ID: 16123970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Osler hemorrhagic telangiectasia syndrome].
    Hamada J; Tanaka K
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):64-5. PubMed ID: 11057144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.